Study to Evaluate the Safety and Immunogenicity of Rabies Vaccine INDIRAB reconstituted with 1mL diluent Vs Reference Vaccine, administered Intramuscularly in healthy volunteers (Pre-Exposure).
Phase of Trial: Phase III
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Rabies vaccine (Primary)
- Indications Rabies
- Focus Pharmacodynamics
- Sponsors Bharat Biotech
- 01 Aug 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
- 18 Mar 2010 New trial record